Gene therapy refers to the insertion of genetic material to correct a genetic defect.
In gene therapy, a "normal" gene is inserted into the genome to replace an "abnormal," disease-causing gene
This document discusses gene therapy, including its strategies, methods of delivery, history, and applications. It provides an overview of key concepts such as:
1. Gene therapy aims to treat genetic diseases by inserting normal genes into cells to compensate for abnormal genes. Strategies include gene replacement, gene augmentation, and gene inhibition.
2. Viruses are commonly used as vectors to deliver therapeutic genes. Retroviruses and adenoviruses integrate into the genome but can cause mutations, while adenoviruses are safer but less efficient.
3. The basic process involves isolating the normal gene, inserting it into a viral vector, infecting target cells, and having the cells produce functional proteins to return to
Gene therapy is a technique used to substitute defective genes that cause diseases with functional genes. It involves identifying the defective gene, extracting DNA, inserting a functional gene, and reinserting the modified DNA. There are two main types of gene therapy - somatic cell gene therapy, which treats only the individual and is not hereditary, and germline cell gene therapy, which could affect future generations but may be most effective. Gene therapy delivers the new genes via viral or bacterial vectors and holds promise to cure genetic diseases but also poses risks such as immune reactions or unintended effects.
The document discusses gene therapy, including:
1. Defining genes and discussing early milestones in gene isolation and engineering.
2. Explaining the goal of gene therapy to introduce normal genes to compensate for defective genes.
3. Describing various methods of gene delivery including viral and non-viral vectors.
4. Discussing challenges in targeting specific cells/tissues and ensuring safe expression levels.
Gene therapy seeks to modify or manipulate genes to treat diseases. There are three main strategies for gene therapy: gene augmentation therapy which introduces a normal gene to compensate for an abnormal gene, targeted killing of specific cells, and targeted inhibition of gene expression. Gene therapy can be somatic, affecting most body cells, or germline, affecting eggs or sperm. Viral vectors are commonly used to deliver genes into cells, but non-viral methods also exist. Gene editing tools like ZFNs, TALENs, and CRISPR-Cas systems can also be used to precisely alter genes.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. The slides explain what is gene tharapy? Types of gene therapy. http://www.wesrch.com/
This document discusses gene therapy, including its strategies, methods of delivery, history, and applications. It provides an overview of key concepts such as:
1. Gene therapy aims to treat genetic diseases by inserting normal genes into cells to compensate for abnormal genes. Strategies include gene replacement, gene augmentation, and gene inhibition.
2. Viruses are commonly used as vectors to deliver therapeutic genes. Retroviruses and adenoviruses integrate into the genome but can cause mutations, while adenoviruses are safer but less efficient.
3. The basic process involves isolating the normal gene, inserting it into a viral vector, infecting target cells, and having the cells produce functional proteins to return to
Gene therapy is a technique used to substitute defective genes that cause diseases with functional genes. It involves identifying the defective gene, extracting DNA, inserting a functional gene, and reinserting the modified DNA. There are two main types of gene therapy - somatic cell gene therapy, which treats only the individual and is not hereditary, and germline cell gene therapy, which could affect future generations but may be most effective. Gene therapy delivers the new genes via viral or bacterial vectors and holds promise to cure genetic diseases but also poses risks such as immune reactions or unintended effects.
The document discusses gene therapy, including:
1. Defining genes and discussing early milestones in gene isolation and engineering.
2. Explaining the goal of gene therapy to introduce normal genes to compensate for defective genes.
3. Describing various methods of gene delivery including viral and non-viral vectors.
4. Discussing challenges in targeting specific cells/tissues and ensuring safe expression levels.
Gene therapy seeks to modify or manipulate genes to treat diseases. There are three main strategies for gene therapy: gene augmentation therapy which introduces a normal gene to compensate for an abnormal gene, targeted killing of specific cells, and targeted inhibition of gene expression. Gene therapy can be somatic, affecting most body cells, or germline, affecting eggs or sperm. Viral vectors are commonly used to deliver genes into cells, but non-viral methods also exist. Gene editing tools like ZFNs, TALENs, and CRISPR-Cas systems can also be used to precisely alter genes.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. The slides explain what is gene tharapy? Types of gene therapy. http://www.wesrch.com/
GENE THERAPY: TYPES, METHODS, FACTORS AND STANDARDS AND ITS APPLICATION IN HEALTHCARE FIELD
INVIVO THERAPY AND EXVIVO THERAPY
CHEMICAL AND PHYSICAL METHODS TO CARRY ON GENE THERAPY
DEFECTIVE GENE IDENTIFICATION IN GENE THERAPY AND TREATMENT OF GENETICALLY AFFECTED GENE BY GENE THERAPY
This document discusses gene therapy and its potential to treat diseases. It provides an overview of genes and how mutations can cause disease. Gene therapy involves inserting functional genes into patients' cells to replace mutated genes that cause illness. Viruses called vectors are used to deliver therapeutic genes into target cells. Some common vector types discussed are retroviruses, adenoviruses, and adeno-associated viruses. Both ex vivo and in vivo gene therapy approaches are described. The document reviews the history of gene therapy and various clinical trials that have been conducted to treat diseases like cancer, cystic fibrosis, and immunodeficiencies.
Gene therapy involves modifying genes to treat or cure disease. It works by replacing mutated genes, inactivating abnormal genes, or introducing new genes. Early successes treated immune deficiencies, but challenges remain in achieving long-term effects without side effects. Promising areas are treating inherited retinal diseases and Parkinson's through localized delivery of therapeutic genes using viral or non-viral vectors. While offering potential cures, gene therapy also raises ethical issues that require ongoing discussion.
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
This document discusses gene therapy and its various aspects. It defines gene therapy as a method of treatment using genes or DNA instead of drugs to treat diseases caused by defective genes. The DNA is delivered into cells using vectors like viruses. The document discusses two main types of gene therapy - somatic cell therapy which affects only the treated individual, and germ line therapy which affects future generations. It also discusses various gene therapy strategies, vectors, methods of gene delivery and challenges in gene therapy.
This document outlines a seminar topic on somatic cell gene therapy. It discusses the different types of gene therapy, including somatic cell gene therapy and germ line gene therapy. Somatic cell gene therapy involves transferring genes into any cell other than germ cells to treat an individual patient only. The document then describes the various types of somatic cell gene therapy in more detail, such as ex-vivo gene therapy, in-vivo gene therapy using viruses, and antisense gene therapy. It also reviews some advantages and disadvantages of gene therapy.
This document discusses gene therapy, including its history, mechanisms, applications, challenges, and recent developments. It provides an overview of the first human gene therapy trials in 1990 for severe combined immunodeficiency, as well as both successful and unsuccessful early gene therapy cases. Recent progress includes using gene therapy to potentially treat Parkinson's disease, cancer, blood disorders, and inherited blindness. Overall, the document outlines the key concepts and timeline of gene therapy from its beginnings to current research.
This document discusses several applications of biotechnology in medicine, including the production of human insulin, human growth hormone, vaccines, and gene therapy. It provides details on how recombinant DNA technology is used to produce these therapeutic products. Human insulin is extracted from pancreas cells and inserted into bacterial plasmids to be mass produced. Vaccines like hepatitis B vaccine involve isolating antigen genes and expressing them in yeast or bacteria. Gene therapy approaches like ex vivo therapy aim to correct genetic disorders by isolating cells, adding functional genes, and reinserting the cells.
Advances in biochemistry and molecular biology have helped to understand the genetic basis of inherited diseases.
Gene therapy was once considered a fantasy (imaginary).
It was a dream of the researchers to replace the defective genes with good ones and cure the genetic disorders.
Gene therapy involves introducing functional genes into patients to treat diseases. It has three main steps: identifying the defective gene, cloning the normal gene, and inserting the normal gene into target cells. There are two main approaches - ex vivo, where cells are removed and modified before being returned, and in vivo, where genes are directly inserted. Gene therapy aims to either augment gene function for loss of function mutations or inhibit gene expression for negative dominant mutations. While promising results have been seen for some diseases, risks still include immune reactions and insertional mutagenesis.
Gene therapy involves delivering genes to correct genetic abnormalities. The first successful gene therapy treated a girl with severe combined immunodeficiency. Gene therapy can replace, deactivate, introduce, or enhance genes to treat diseases. Viral and non-viral vectors are used to deliver genes. While gene therapy has treated some genetic diseases and cancers, it remains imperfect as many diseases involve multiple genes and genes can be difficult to target precisely without risks.
Gene therapy : Types, Gene transfer methods vectors for gene therapy approach...Shivkumar Sammeta
Gene therapy: Types of Gene therapy Gene transfer methods vectors for gene therapy approaches applications advantages and disadvantages. Gene therapy based drugs. Ethical considerations.
The document discusses genes and genetic disorders. It defines a gene as the basic physical and functional unit of heredity, and notes that genes are segments of DNA that code for specific traits. Genetic disorders are caused by variations or mutations in genes. The document then discusses recent discoveries in epigenetics, gene marking, and gene therapy. Gene therapy involves introducing new genes into cells to treat diseases, either by replacing defective genes, inactivating abnormal genes, or introducing new genes to fight diseases. Various gene therapy approaches and vectors, including viral vectors like retroviruses and adenoviruses, are described.
Gene therapy is a technique for correcting defective genes that cause disease. It works by inserting a normal gene to replace a missing or defective one. The first human gene therapy treatment was in 1990 for ADA deficiency. There are two main types - germline alters genes in sperm/eggs and is inheritable, while somatic only affects the patient. Delivery methods include viruses, electroporation, gene guns, and chemicals. Applications show promise for diseases like Parkinson's, Alzheimer's, cystic fibrosis and cancer. Current trends include improving viral vectors and combining gene and cell therapies.
Gene therapy is an approach to treating diseases by modifying or correcting abnormal genes. It can involve replacing a mutated gene, inactivating an abnormal gene, or introducing a new gene. While the concept was introduced in the 1960s, the first approved human gene therapy trial took place in 1990. Since then, gene therapy has successfully treated various diseases like blindness, immune deficiencies, and Parkinson's disease symptoms. Viral and non-viral vectors are used to deliver therapeutic genes, with both methods having advantages and disadvantages. Ongoing research continues to expand the diseases that can be treated with this promising approach.
Gene therapy involves introducing normal genes into patients to replace abnormal genes that cause disease. Viruses are often used as vectors to deliver therapeutic genes to target cells. While promising for treating genetic disorders, gene therapy faces challenges like short-lived effects, immune responses, and difficulties targeting multi-gene disorders. It also raises ethical issues around heritable genetic modifications and access to expensive new treatments. Continued research aims to address these scientific and ethical considerations to realize gene therapy's potential.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. It works by inserting a normal gene to replace a defective gene that is causing disease. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia, blindness, and Parkinson's disease. There are two main types - germline gene therapy, which results in permanent changes that can be inherited, and somatic gene therapy, which only affects the patient. Gene delivery methods include viral vectors like retroviruses and adenoviruses, as well as non-viral methods using physical approaches or chemical carriers like liposomes and polymers. Some successful applications of gene therapy include treating blindness and reducing Parkinson's disease symptoms.
This document discusses biopharmaceuticals, which are medical drugs produced using biotechnology. It classifies biopharmaceuticals into several categories, including monoclonal antibodies, vaccines, thrombotic agents, interferons, blood factors, and hormones. Interferons are proteins produced by immune cells in response to challenges from viruses and tumors. They help the immune response by inhibiting viral replication and activating immune cells. Interferons are commercially produced from lymphocytes isolated from blood and induced to produce interferons. Biopharmaceuticals have advantages like being highly effective, specific, and safer than other drugs, with fewer side effects. They have many commercial applications in treating conditions like anemia, cancers, hepatitis B, and more. Biopharmaceuticals
The document discusses gene therapy and its potential to treat genetic diseases. It describes how gene therapy works by introducing functional genes into cells to replace defective genes causing disease. The first approved gene therapy treated a girl with ADA-SCID by inserting a functional ADA gene. While promising, gene therapy faces challenges like short-lived effects and safety issues that must still be addressed.
This document discusses gene therapy and genetic engineering. It distinguishes between gene therapy, which aims to treat disease by replacing mutated genes, and genetic enhancement, which aims to modify humans in a way that goes beyond curing illness or disability. While gene therapy seeks to cure disease and is considered acceptable, genetic enhancement that modifies humans to make them "super human" raises ethical issues and is generally not supported by the Catholic Church. The key distinction is that gene therapy should be therapeutic and only done to promote health, while genetic enhancement goes beyond therapy and could worsen conditions or unfairly advantage some individuals.
GENE THERAPY: TYPES, METHODS, FACTORS AND STANDARDS AND ITS APPLICATION IN HEALTHCARE FIELD
INVIVO THERAPY AND EXVIVO THERAPY
CHEMICAL AND PHYSICAL METHODS TO CARRY ON GENE THERAPY
DEFECTIVE GENE IDENTIFICATION IN GENE THERAPY AND TREATMENT OF GENETICALLY AFFECTED GENE BY GENE THERAPY
This document discusses gene therapy and its potential to treat diseases. It provides an overview of genes and how mutations can cause disease. Gene therapy involves inserting functional genes into patients' cells to replace mutated genes that cause illness. Viruses called vectors are used to deliver therapeutic genes into target cells. Some common vector types discussed are retroviruses, adenoviruses, and adeno-associated viruses. Both ex vivo and in vivo gene therapy approaches are described. The document reviews the history of gene therapy and various clinical trials that have been conducted to treat diseases like cancer, cystic fibrosis, and immunodeficiencies.
Gene therapy involves modifying genes to treat or cure disease. It works by replacing mutated genes, inactivating abnormal genes, or introducing new genes. Early successes treated immune deficiencies, but challenges remain in achieving long-term effects without side effects. Promising areas are treating inherited retinal diseases and Parkinson's through localized delivery of therapeutic genes using viral or non-viral vectors. While offering potential cures, gene therapy also raises ethical issues that require ongoing discussion.
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
This document discusses gene therapy and its various aspects. It defines gene therapy as a method of treatment using genes or DNA instead of drugs to treat diseases caused by defective genes. The DNA is delivered into cells using vectors like viruses. The document discusses two main types of gene therapy - somatic cell therapy which affects only the treated individual, and germ line therapy which affects future generations. It also discusses various gene therapy strategies, vectors, methods of gene delivery and challenges in gene therapy.
This document outlines a seminar topic on somatic cell gene therapy. It discusses the different types of gene therapy, including somatic cell gene therapy and germ line gene therapy. Somatic cell gene therapy involves transferring genes into any cell other than germ cells to treat an individual patient only. The document then describes the various types of somatic cell gene therapy in more detail, such as ex-vivo gene therapy, in-vivo gene therapy using viruses, and antisense gene therapy. It also reviews some advantages and disadvantages of gene therapy.
This document discusses gene therapy, including its history, mechanisms, applications, challenges, and recent developments. It provides an overview of the first human gene therapy trials in 1990 for severe combined immunodeficiency, as well as both successful and unsuccessful early gene therapy cases. Recent progress includes using gene therapy to potentially treat Parkinson's disease, cancer, blood disorders, and inherited blindness. Overall, the document outlines the key concepts and timeline of gene therapy from its beginnings to current research.
This document discusses several applications of biotechnology in medicine, including the production of human insulin, human growth hormone, vaccines, and gene therapy. It provides details on how recombinant DNA technology is used to produce these therapeutic products. Human insulin is extracted from pancreas cells and inserted into bacterial plasmids to be mass produced. Vaccines like hepatitis B vaccine involve isolating antigen genes and expressing them in yeast or bacteria. Gene therapy approaches like ex vivo therapy aim to correct genetic disorders by isolating cells, adding functional genes, and reinserting the cells.
Advances in biochemistry and molecular biology have helped to understand the genetic basis of inherited diseases.
Gene therapy was once considered a fantasy (imaginary).
It was a dream of the researchers to replace the defective genes with good ones and cure the genetic disorders.
Gene therapy involves introducing functional genes into patients to treat diseases. It has three main steps: identifying the defective gene, cloning the normal gene, and inserting the normal gene into target cells. There are two main approaches - ex vivo, where cells are removed and modified before being returned, and in vivo, where genes are directly inserted. Gene therapy aims to either augment gene function for loss of function mutations or inhibit gene expression for negative dominant mutations. While promising results have been seen for some diseases, risks still include immune reactions and insertional mutagenesis.
Gene therapy involves delivering genes to correct genetic abnormalities. The first successful gene therapy treated a girl with severe combined immunodeficiency. Gene therapy can replace, deactivate, introduce, or enhance genes to treat diseases. Viral and non-viral vectors are used to deliver genes. While gene therapy has treated some genetic diseases and cancers, it remains imperfect as many diseases involve multiple genes and genes can be difficult to target precisely without risks.
Gene therapy : Types, Gene transfer methods vectors for gene therapy approach...Shivkumar Sammeta
Gene therapy: Types of Gene therapy Gene transfer methods vectors for gene therapy approaches applications advantages and disadvantages. Gene therapy based drugs. Ethical considerations.
The document discusses genes and genetic disorders. It defines a gene as the basic physical and functional unit of heredity, and notes that genes are segments of DNA that code for specific traits. Genetic disorders are caused by variations or mutations in genes. The document then discusses recent discoveries in epigenetics, gene marking, and gene therapy. Gene therapy involves introducing new genes into cells to treat diseases, either by replacing defective genes, inactivating abnormal genes, or introducing new genes to fight diseases. Various gene therapy approaches and vectors, including viral vectors like retroviruses and adenoviruses, are described.
Gene therapy is a technique for correcting defective genes that cause disease. It works by inserting a normal gene to replace a missing or defective one. The first human gene therapy treatment was in 1990 for ADA deficiency. There are two main types - germline alters genes in sperm/eggs and is inheritable, while somatic only affects the patient. Delivery methods include viruses, electroporation, gene guns, and chemicals. Applications show promise for diseases like Parkinson's, Alzheimer's, cystic fibrosis and cancer. Current trends include improving viral vectors and combining gene and cell therapies.
Gene therapy is an approach to treating diseases by modifying or correcting abnormal genes. It can involve replacing a mutated gene, inactivating an abnormal gene, or introducing a new gene. While the concept was introduced in the 1960s, the first approved human gene therapy trial took place in 1990. Since then, gene therapy has successfully treated various diseases like blindness, immune deficiencies, and Parkinson's disease symptoms. Viral and non-viral vectors are used to deliver therapeutic genes, with both methods having advantages and disadvantages. Ongoing research continues to expand the diseases that can be treated with this promising approach.
Gene therapy involves introducing normal genes into patients to replace abnormal genes that cause disease. Viruses are often used as vectors to deliver therapeutic genes to target cells. While promising for treating genetic disorders, gene therapy faces challenges like short-lived effects, immune responses, and difficulties targeting multi-gene disorders. It also raises ethical issues around heritable genetic modifications and access to expensive new treatments. Continued research aims to address these scientific and ethical considerations to realize gene therapy's potential.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. It works by inserting a normal gene to replace a defective gene that is causing disease. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia, blindness, and Parkinson's disease. There are two main types - germline gene therapy, which results in permanent changes that can be inherited, and somatic gene therapy, which only affects the patient. Gene delivery methods include viral vectors like retroviruses and adenoviruses, as well as non-viral methods using physical approaches or chemical carriers like liposomes and polymers. Some successful applications of gene therapy include treating blindness and reducing Parkinson's disease symptoms.
This document discusses biopharmaceuticals, which are medical drugs produced using biotechnology. It classifies biopharmaceuticals into several categories, including monoclonal antibodies, vaccines, thrombotic agents, interferons, blood factors, and hormones. Interferons are proteins produced by immune cells in response to challenges from viruses and tumors. They help the immune response by inhibiting viral replication and activating immune cells. Interferons are commercially produced from lymphocytes isolated from blood and induced to produce interferons. Biopharmaceuticals have advantages like being highly effective, specific, and safer than other drugs, with fewer side effects. They have many commercial applications in treating conditions like anemia, cancers, hepatitis B, and more. Biopharmaceuticals
The document discusses gene therapy and its potential to treat genetic diseases. It describes how gene therapy works by introducing functional genes into cells to replace defective genes causing disease. The first approved gene therapy treated a girl with ADA-SCID by inserting a functional ADA gene. While promising, gene therapy faces challenges like short-lived effects and safety issues that must still be addressed.
This document discusses gene therapy and genetic engineering. It distinguishes between gene therapy, which aims to treat disease by replacing mutated genes, and genetic enhancement, which aims to modify humans in a way that goes beyond curing illness or disability. While gene therapy seeks to cure disease and is considered acceptable, genetic enhancement that modifies humans to make them "super human" raises ethical issues and is generally not supported by the Catholic Church. The key distinction is that gene therapy should be therapeutic and only done to promote health, while genetic enhancement goes beyond therapy and could worsen conditions or unfairly advantage some individuals.
Medical biotechnology uses living cells and materials to research and produce pharmaceuticals and diagnostics for treating human diseases. It is applied to produce things like enzymes, antibiotics, vaccines, and for molecular diagnostics. Key applications of medical biotechnology include pharmacology, gene therapy, stem cells, and tissue engineering. Pharmacology uses techniques like recombinant DNA to produce therapeutic proteins in cells like insulin, growth hormone, and clotting factors. Gene therapy aims to treat diseases by replacing mutated genes. Stem cells have potential to regenerate tissues and treat conditions like spinal cord injuries. Tissue engineering grows tissues on scaffolds for transplantation.
This document provides an overview of gene therapy. It defines key terms like genetics, genes, chromosomes, and therapy. It explains that gene therapy involves inserting a normal gene to replace an abnormal gene causing disease. Viruses and non-viral methods can be used as vectors to deliver therapeutic genes. While some gene therapies have shown promise for diseases like Parkinson's and immune deficiencies, the field has also faced challenges. Safety issues in early trials halted some research, but recent studies demonstrate progress in refining methods and potentially treating diseases like sickle cell anemia.
Gene therapy involves techniques that modify or manipulate genes to treat or prevent diseases. The first gene therapy treatment occurred in 1990 for severe combined immunodeficiency. There are four main approaches to gene therapy: inserting a normal gene to compensate for a defective one, replacing an abnormal gene with a normal one, repairing an abnormal gene, or altering gene regulation. Viruses are commonly used as vectors to deliver therapeutic genes into target cells, with retroviruses, adenoviruses, adeno-associated viruses, and herpes simplex viruses being some of the most widely used viral vectors, each with advantages and limitations.
Gene therapy is an experimental technique that uses genes to treat disease by inserting genes into patients' cells instead of using drugs or surgery. Recent research has shown promising advances in gene therapy to treat various diseases. However, gene therapy still faces technical challenges such as safely delivering genes to target cells and tissues, potential immune responses, and difficulty treating complex multigenic disorders. While still experimental, gene therapy offers hope for treating currently incurable conditions.
Gene therapy involves introducing normal genes into patients to compensate for mutated genes that cause disease. The first gene therapy trial treated a girl with severe combined immunodeficiency. While it initially strengthened her immune system, the effects only lasted a few months. Gene therapy shows promise for diseases caused by single gene defects like cystic fibrosis, but faces challenges like short-lived effects, immune responses, and safety issues. Continued research aims to address these challenges through techniques like RNA interference and improved gene delivery methods.
The sequencing of the human genome has been compared to putting a man on the moon, and it will certainly change health care, but the most important work lies ahead, in determining how to put the information to medical use. In this context, applications such as gene therapy are being explored. What was once seen as a science fiction dream is now becoming a real possibility.
Gene therapy is a new form of drug delivery that leads the patient's own cells to produce a therapeutic agent. It could potentially eliminate the need for repeated administration of proteins or drugs. Applications of gene therapy not only include rare inherited diseases but extend to common acquired disorders, including tumours (predominantly malignant melanoma) and haematological disorders, cardiovascular disease, and the acquired immunodeficiency syndrome. Gene therapy therefore could be a key element of medical practice in the future. Gene therapy is the insertion of genes into an individual's cells and tissues to treat a disease, and hereditary diseases in which a defective mutant allele is replaced with a functional one. Although the technology is still in its infancy, it has been used with some success. Antisense therapy is not strictly a form of gene therapy, but is a genetically-mediated therapy and is often considered together with other methods.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches (see video: 'Gene Therapy a new tool to cure human diseases'). A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy, but it has been used with some success.
Gene therapy involves inserting normal genes into patients to replace abnormal genes that cause disease. It is being studied for many diseases like immunodeficiencies, hemophilia, Parkinson's, and cancer. The first gene therapy occurred in 1990 and involved treating a genetic immune deficiency. While it offers potential cures, there are also risks and ethical concerns around its use.
These slide include gene therapy defines with their types like Germ line gene therapy,Somatic gene therapy.
with Need of Gene therapy
strategies of gene therapy
Methods of Gene transfer & with
GENE THERAPY FOR INHERITED DISORDERS
Gene therapy holds promise for treating diseases like cancer, HIV, and genetic disorders. It works by inserting a normal gene to replace an abnormal one causing disease. Viruses are often used as vectors to deliver the new gene into cells. There are two main types: germline alters genes in reproductive cells and is unethical, while somatic only alters genes in other body cells. Gene therapy has had some success but also deaths, and faces ethical issues regarding cost, safety, and enhancement versus treatment of disease. It remains experimental but could help many if developed responsibly.
Biopharmaceuticals are large protein molecules that target the mechanisms of disease. They are produced through recombinant DNA technology by genetically engineering bacteria or fungi to produce the target protein, or through purification from blood or plasma. Biopharmaceuticals are used to treat conditions like cancer, heart disease, and immune disorders. Gene therapy and genetic testing are also applied to develop new treatments and further understand disease mechanisms.
Antibiotics as a tool in biotechnology - Classroom activitiesXplore Health
Antibiotics are substances that are toxic to bacteria at low doses but innocuous to human
beings. Hence, at the proper dosage, antibiotics can be used to treat diseases of a bacterial origin. In
addition, antibiotics have other applications in research. In this teaching unit you will learn about one
of the uses of bacteria in biotechnology.
Over 300 million families worldwide are affected by inherited hemoglobin diseases but CRISPR gene editing offers a potential cure. The document outlines a treatment strategy using CRISPR to modify the hemoglobin gene in patients, allowing production of functional fetal hemoglobin and a cure. This approach has shown promise in genetically modifying cells to increase fetal hemoglobin levels by 100%, and the goal is to benefit millions through clinical trials and an approved therapy by 2035.
This document summarizes the history and development of gene therapy from the 1950s to the present. It discusses key events like the isolation of genes in the 1970s and 1980s and the first human gene therapy treatment in 1990. It outlines various gene therapy strategies like ex vivo and in vivo approaches and delivery methods like viruses, liposomes, microinjection, and electroporation. Challenges of gene therapy are also summarized like ethical issues, high costs, and ensuring safety. The document aims to provide an overview of the progress of gene therapy and remaining barriers to its clinical application and acceptance.
Gene therapy involves introducing functional genes into patients' cells to treat diseases caused by defective genes. It works by replacing mutated genes with healthy copies, inactivating mutated genes, or introducing new genes to fight diseases. The process involves identifying the defective gene, cloning the normal gene, selecting target cells, and inserting the functional gene into the host DNA using viruses to deliver the new gene. Engineered cells are then injected into patients so the functional gene can correct the disorder.
Maurice Oyoo: Biotechnology as a tool for improved agricultural yield as a re...AfricaAdapt
1) Biotechnology can help improve agricultural productivity and address issues caused by climate change such as increasing temperatures, reduced arable land, and declining crop yields.
2) Traits related to heat, drought, and pest/disease tolerance can be engineered into crops using biotechnology to help them adapt to changing conditions caused by climate change.
3) Adopting biotechnology and more sustainable farming practices such as no-till can help reduce greenhouse gas emissions from agriculture and increase carbon sequestration in soils.
Will reimbursement prove to be the biggest barrier as three gene therapies gain regulatory approval?
Datamonitor Healthcare has carried out a comprehensive analysis of gene therapy products in commercial development worldwide based on information derived from Pharmaprojects. The results have been analyzed to reveal trends in gene therapy technologies and approaches to the treatment of different diseases.
The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products – Glybera (uniQure), Imlygic (Amgen), and Strimvelis (GlaxoSmithKline) – have now received regulatory approval in Europe. While these approvals give some validation to gene therapy as a therapeutic strategy, doubts remain around their return on investment. The high upfront costs and residual uncertainty around the long-term benefits of gene therapy products are proving to be hurdles to wider access and reimbursement, but seem to have had a minimal impact on companies’ appetite to dive into this arena, with cancer and monogenic diseases proving to be the most popular indications for the development of gene therapy products.
For more information on this report visit https://pharmastore.informa.com/product/trends-gene-therapy/
Gene therapy is a technique for correcting defective genes that cause disease. There are four main approaches: inserting a normal gene, replacing an abnormal gene, repairing an abnormal gene, or changing gene regulation. The first gene therapy treated a girl with severe combined immunodeficiency in 1990 by removing her white blood cells, inserting the missing gene, and returning the cells. While some early gene therapies showed promise, they also led to deaths and halted further research for a time due to immune reactions. Recent research focuses on improving viral vectors and non-viral delivery methods to more safely introduce therapeutic genes. Some conditions like Parkinson's disease and sickle cell anemia have shown success in animal studies.
Gene therapy involves introducing normal genes into patients to compensate for mutated genes that cause disease. It works by using a vector to deliver the therapeutic gene into a target cell, allowing functional proteins to be produced and returning the cell to a normal state. There are two main types - germline gene therapy, which can pass therapeutic effects to future generations, and somatic gene therapy, which only affects the individual patient. While initial gene therapy trials showed promise, there have also been safety issues, as in 1999 a patient died due to an immune response to the adenovirus vector. Researchers continue working to address risks before conducting further human clinical trials.
This document provides an overview of gene therapy, including its history, approaches, delivery methods, applications, and challenges. Gene therapy involves introducing a normal gene into cells containing a defective gene in order to correct the underlying genetic disorder. It can be carried out in vivo by using viral vectors to deliver the therapeutic gene directly into patients, or in vitro by manipulating cells outside the body before reintroducing them. Many genetic diseases have been targeted, including immunodeficiencies, cancers, hemoglobinopathies, and rare diseases. While gene therapy holds promise, challenges remain such as short-lived effects, immune responses, and ethical concerns.
This document provides an overview of gene therapy, including its history, mechanisms, and applications. It discusses how gene therapy works to replace abnormal genes, introduces new genes to fight disease, or enhances normal gene function. The document outlines the types of gene therapy based on the cells targeted, such as somatic or germ line cells. It also reviews the vectors used to deliver genes, including viral vectors like retroviruses and non-viral methods. The text highlights some accomplishments of gene therapy and diseases it may help treat, but notes there are also ethical concerns around its use.
Gene therapy involves introducing genes into cells to treat disease. It works by correcting defective genes that cause diseases. The first approved gene therapy occurred in 1990 when a child with ADA-SCID was treated. There are two main types of gene therapy - somatic cell therapy targets body cells while germline therapy affects eggs and sperm. Significant challenges remain for gene therapy including developing safe methods for long-term effects and ensuring equitable access to new treatments. However, gene therapy has potential to cure many inherited diseases and revolutionize medicine.
Gene therapy involves inserting normal genes into cells to treat genetic diseases. The first successful gene therapy trial treated a patient with severe combined immunodeficiency (SCID) caused by adenosine deaminase (ADA) deficiency. The procedure involved removing the patient's lymphocytes, infecting them with a retrovirus carrying the normal ADA gene, allowing the gene to integrate and express ADA, and returning the modified lymphocytes to the patient to permanently produce the enzyme. This landmark trial established gene therapy as a viable treatment approach for genetic diseases.
Gene therapy involves inserting normal genes into a person's cells to treat a disease. There are several strategies for gene therapy, including ex vivo and in vivo methods. Viral vectors are commonly used to deliver therapeutic genes to target cells. However, gene therapy has faced challenges such as short-lived effects, immune responses, and safety issues with viral vectors. Continued research is working to overcome these issues and further develop promising applications of gene therapy.
Gene therapy involves introducing normal genes into cells to replace missing or defective genes and correct genetic disorders. The first gene therapy treatment occurred in 1990 for SCID. There are two main types - germline therapy would alter the germ cells and be heritable, while somatic therapy only affects the individual. Delivery of genes requires vectors like viruses that can transport the new gene into target cells. Challenges include developing vectors that don't cause immune responses, achieving long-term expression of the gene, and addressing disorders influenced by multiple genes. Risks include insertional mutagenesis and the development of tumors.
Gene therapy involves inserting functional genes into patients' cells to treat genetic diseases. It was first proposed in the 1960s and attempted in the 1970s. The first approved human gene therapy trial took place in 1990, treating a girl with severe combined immunodeficiency. Since then, gene therapy has been used experimentally to treat various diseases including cancer, cystic fibrosis, and HIV. There are two main approaches - ex vivo, where cells are removed and modified before being returned to the body, and in vivo, where genes are directly inserted into target tissues. Viruses are often used as vectors to deliver therapeutic genes, with retroviruses commonly used for ex vivo therapy and adenoviruses for in vivo.
Gene therapy involves introducing genes into cells to treat or prevent disease. It works by correcting defective genes that cause disease or by making cells produce products to treat the disease. The first approved gene therapy treated a girl for ADA-SCID. There are two main approaches - in vivo therapy directly delivers genes into body cells, while ex vivo therapy transfers genes to cultured cells before reinsertion. Viral vectors like retroviruses and adenoviruses are often used due to their ability to deliver genes, but come with risks like insertional mutagenesis. Non-viral methods include physical methods like microinjection and chemical methods using liposomes. Gene therapy shows promise for diseases like cancer, cardiovascular disease, and neurological disorders.
Gene therapy involves inserting normal genes into patients to compensate for mutated genes that cause disease. There are four main approaches: gene replacement, gene correction, gene regulation, or selective mutation reversal. The first gene therapy treated a girl with severe combined immunodeficiency by removing her white blood cells, inserting the missing gene, and returning the cells. While some early attempts showed promise, others led to patient deaths due to immune reactions. Current research focuses on developing safer viral and non-viral methods of gene delivery to address issues like short-term effects, immune responses, and control over insertion location. Recent successful human trials have treated immunodeficiency, muscular dystrophy, and Parkinson's disease.
Gene therapy involves inserting normal genes into patients to compensate for mutated genes that cause disease. There are four main approaches: gene replacement, gene correction, gene regulation, or selective mutation reversal. The first gene therapy treated a girl for severe combined immunodeficiency in 1990 by removing her white blood cells, inserting the missing gene, and returning the cells. While some early gene therapies showed promise, they also encountered problems like short-lived effects, immune responses, and in rare cases caused leukemia. Recent research aims to improve vectors and target delivery to overcome past issues. The first successful human gene therapy trials treated immunodeficiency and Parkinson's disease with no reported adverse events.
Nucleic acid and cell based therapies involve gene therapy and cell therapy. Gene therapy aims to introduce new genes into cells to treat genetic diseases by replacing defective genes. Early gene therapy trials focused on ex vivo and in vivo approaches. Viral vectors like retroviruses were primarily used but posed safety risks. Non-viral methods using naked DNA or vectors like liposomes were developed. Diseases targeted include cancer, genetic disorders, and AIDS. Antisense oligonucleotides can bind mRNA and inhibit gene expression. RNA interference uses short interfering RNAs to induce sequence-specific gene silencing. Ribozymes and aptamers also provide nucleic acid based therapeutic approaches.
Gene therapy involves introducing genes into cells to treat disease. The first approved gene therapy treated a girl named Ashanti DeSilva for ADA-SCID in 1990. There are two main types: somatic cell gene therapy targets body cells and is not inherited, while germline gene therapy targets germ cells and is inherited. Gene therapy holds promise for treating genetic diseases but also faces challenges in achieving long-term effects, immune responses, and ethical concerns.
NUCLEIC ACID BASED THERAPEUTIC DELIVERY SYSTEM by pramesh..pptxPRAMESHPANWAR1
Name of the title: Nucleic Acid-Based Therapeutic Delivery System.
It includes information about nucleic acid, gene therapy, and its type, a method to deliver the desired DNA, i.e., vectors and their types, with proper examples and diagrams, and how these things help in delivering a nucleic acid-based therapeutic drug delivery system.
Gene therapy and stem cells are discussed. [1] Gene therapy involves delivering genetic material into cells for therapeutic purposes using vectors. It aims to replace defective genes, enhance gene expression, or suppress harmful genes. [2] Stem cells are undifferentiated cells that can develop into specialized cell types and have self-renewal abilities. There are embryonic, adult tissue specific, and induced pluripotent stem cells. Gene therapy and stem cells offer potential treatments for diseases like cancer, genetic disorders, and tissue regeneration. However, safety and delivery challenges remain.
This document provides an overview of gene therapy, including types, approaches, vectors used, methods of delivery, advantages, disadvantages, applications, and recent advances. It discusses somatic cell gene therapy, which aims to correct genetic defects in non-reproductive cells, and germline gene therapy, which could pass alterations to future generations but poses more risks. Ex vivo and in vivo gene therapy approaches are described. Viral and non-viral vectors as well as various delivery methods are outlined. Some applications including cystic fibrosis and cancer are highlighted. Risks and ethical considerations are also mentioned.
Gene therapy involves inserting genes into an individual's cells and tissues to treat disease. It can replace mutated genes, inactivate genes, introduce new genes, or cause cancer cells to kill themselves. Viral and non-viral vectors are used to deliver genes. Gene therapy has been applied to treat genetic disorders, cancer, heart disease, and more. Recent advances include using gene therapy to regenerate heart muscle cells, treat Sanfilippo syndrome and brain cancers, and combining cellular and gene therapies for breast cancer. RNA and DNA can be estimated using reactions that form colored complexes measured spectrophotometrically.
Similar to Advancements of medical biotechnology in gene therapy (20)
A stem cell is a "blank" cell that can give rise to multiple tissue types such as a skin, muscle, or nerve cell.
Under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions.
Vaccines provide protective immunity and immunological memory to individuals, families and communities against any infectious disease.
Vaccines are cheap, cost – effective , easily administered and adaptable to mass vaccination.
Viral diseases can be managed through vaccination.
A community is a complex group of individuals interacting and sharing an environment.
Communities can be characterized by their structure (the types and numbers of species present) and dynamics (how communities change over time).
All behavior patterns are co-ordinated sequences of neuromuscular activity. A rhythm is a periodically recurring event.
chronobiology is the study of science of life in relation with time.
The majority of organisms show daily and annual cycles of activity and development.
Thermodynamic laws describe the flows and interchanges of heat, energy and matter.
Almost all chemical and biochemical processes are as a result of transformation of energy.
Laws can provide important insights into metabolism and bioenergetics.
The energy exchanges between the system and the surroundings balance each other.
There is a hierarchy of energetics among organisms
The active principles of the endocrine glands are called hormones.
Hormones are specific chemical substances discharged directly into the blood.
The blood distributes the hormones through out the body.
Water is one of the prime elements responsible for life on earth.
Water sustains life and maintains ecological balance.
Water is the essential component of global life support system.
The muscle are biological motors which convert chemical energy into force and mechanical work.
This biological machinery is composed of proteins – which is actomyosin and the fuel is ATP.
With the use of muscles we are able to act on our environment.
Nervous system forms an interconnecting fibers of communication network.
In the ‘hard-wiring’ of the nerves, the signals travel in the form of a flow of electrical current called nerve impulses.
The stimulus-response reactions afford internal constancy in the face of environmental changes.
Dr. B. Victor presented on the biochemical principles of enzyme action. Some key points include: enzymes are proteins that act as catalysts to lower the activation energy of biochemical reactions; they have an active site that binds specifically to substrates; the lock and key and induced fit models describe how enzymes and substrates interact; factors like temperature, pH, and inhibitors can impact an enzyme's activity level; and coenzymes, isoenzymes, and allosteric enzymes are types of modified enzymes. Dr. Victor has over 30 years experience teaching biochemistry and guiding PhD students.
Global climate change Refers to changes in any aspects of the earth’s climate including temperature, precipitation and storm intensity and patterns.
Global warming is an increase in Earth’s average surface temperature due to rising levels of greenhouse gases.
The term heavy metal refers to any metallic chemical element that has a relatively high density and is toxic or poisonous at low concentrations.
Heavy metals are Globally distributed
pollutants
The oceans are enormous in their size, volume and depth.
Animal life in the sea is very varied and more diversified in terms shape, size, form and weight-right from microscopic plankton to the giant whale.
Marine pollution is the introduction by man, directly or indirectly, of substances or energy into the marine environment (including estuaries), resulting in such deleterious effects as; harm to living resources: hazards to human health
A biochemical technique used in Molecular Biology to amplify a specific fragment of target DNA.
PCR is used in medical and biological research, including cloning, genetic analysis, genetic fingerprinting, diagnostics, pathogen detection and genetic fingerprinting
Electrophoresis is a separation technique that is based on the movement of charged particles in an electric field.
Electrophoresis is an analytical method of separating charged particles based on their relative mobilities in an electric field
Dr. B. Victor presented on the key aspects of histotechnology. He discussed the meaning and branches of histotechnology, the major steps in tissue processing including fixation, dehydration, clearing, embedding and staining. He described different types of fixatives, their characteristics and principles of tissue fixation. The document also covered the paraffin wax technique, types of microtomes used to cut tissue sections, and various staining techniques including double stains and acid/basic stains.
Soil is a biologically active, complex mixture of minerals, organic materials, living organisms, air and water.
Soil contamination is the presence of man-made chemicals or other alteration to the natural soil environment.
Natural resources are the materials which are required for the survival and prosperity of human beings.
Life of resources can be prolonged by using them diligently
The resources can be useful for a longer period of time and for a larger number of people.
During consumptive use, prevent exploitation, destruction or neglect.
Acid rain is caused by emissions of sulfur dioxide and nitrogen oxides from human activities like burning fossil fuels, and has lowered the pH of rainwater globally. It damages ecosystems, infrastructure, and human health through acidification of soils and waterways. The document outlines the formation, impacts, and geographic distribution of acid rain as well as efforts to mitigate its environmental and economic effects.
More from St.Xavier's College , Palayamkottai - 627 002 (20)
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Assessment and Planning in Educational technology.pptxKavitha Krishnan
In an education system, it is understood that assessment is only for the students, but on the other hand, the Assessment of teachers is also an important aspect of the education system that ensures teachers are providing high-quality instruction to students. The assessment process can be used to provide feedback and support for professional development, to inform decisions about teacher retention or promotion, or to evaluate teacher effectiveness for accountability purposes.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
A Survey of Techniques for Maximizing LLM Performance.pptx
Advancements of medical biotechnology in gene therapy
1. Advancements of Medical
Biotechnology in Gene Therapy
Presented by
Dr. B. Victor., Ph. D
Email : bonfiliusvictor@gmail.com
Blog: bonvictor.blogspot.com
2. Presentation outline
Human genetic disorders-types, features.
Gene therapy- definition, kinds and history.
Somatic cell and Germ line gene therapy
Ex vivo and In vivo gene therapy
Gene delivery vectors: Viral and Non-viral vectors.
Gene targeting
Naked DNA gene therapy, post-natal gene therapy
and pre-natal gene therapy
Risks and recent developments.
Conclusion
6. Functional or
non-functional DNA
Genes are sequences of bases.
Genes replicate exactly.
Gene is transcribed into mRNA.
mRNA is translated into Protein.
Proteins do metabolic functions.
Mutated genes are non-
functional (build wrong, interact
wrong).
Mutated genes are inherited;
result is genetic disease.
10. Concepts of gene therapy
techniques
Replacement of a
abnormal gene with
normal gene.
Repairing the
abnormal gene.
Altering how that
gene is controlled.
Get other cells to
take over function
of abnormal cells.
Inserting correct
protein and bypass
gene function.
16. History of gene therapy :
In the beginning…
◦ In the 1980s, Scientists inserted
human genes into a bacteria cell.
◦ Then the bacteria cell transcribed
and translated the information into a
protein.
◦ Then they introduced the protein
into human cells.
17. The First gene therapy case was
performed on September 14th,
1990.
Ashanti De Silva was
treated for
SCID(Sever combined
immunodeficiency).
Doctors removed her
white blood cells,
inserted the missing
gene into the WBC,
and then put them
back into her blood
stream.
This strengthened her
immune system
This only worked for a
few months.
18. 9/17/1999
Jesse Gelsinger, 18 years
high school graduate with
OTC deficiency, died
participating in a gene
therapy experiment at the
University of Pennsylvania in
Philadelphia,
19. The first gene therapy cure
2000 - The first gene
therapy cure was
reported when Alain
Fischer (Paris)
succeeded in totally
correcting children with
SCID-X1, or “bubble
boy” syndrome
21. Types of gene therapy;
Germ line gene therapy:
Healthy gene is introduced into reproductive
cells
E.g., eggs, sperms.
Somatic cell gene therapy:
Healthy gene is introduced into adult somatic
cells(body cells).
E.g., bone marrow cells, hepatic cells, central
nervous system cells.
Gene addition therapy :
Functional gene is introduced into the somatic
cell in addition to defective gene endogenous
to the cell.
Gene targeting :
Inactivate a functional defective endogenous
gene.
22. ex vivo(in vitro) and in
vivo somatic gene therapy
Ex vivo gene therapy- refers to the
transfer of genes in cultured cells (outside
the body) (e.g., bone marrow cells) which
are then reintroduced into the patient.
This technique is used for treating genetic
diseases of blood system.
In vivo gene therapy- the direct delivery
of genes into the cells of a particular tissue.
This technique is used for treating tissue –
based genetic diseases e.g., Duchenne
muscular dystrophy (DMD).
25. Gene targeting or
targeted gene transfer
It is a form of in-vivo site directed
mutagenesis involving homologous
recombination between a targeting vector
containing one allele and an endogenous
gene represented by a different allele.
Gene targeting can be used either to
inactivate a functional endogenous gene or
to correct a defective gene.
The first case ( in 1985) was used to disrupt
the human b-globin gene in cultured cells.
26. Problems with ex-vivo method
of gene Therapy
Problems Risks
Not enough cells Cells injected may
get desired gene cause an immune
to correct response
problem Random insertion of
Modified cells retrovirus into host
don’t last long; chromosome- may
need repeat likely to interrupt the
treatments coding DNA.
29. Characteristics of ideal gene
delivery vector system
an adequate carrying capacity.
to be undetectable by the immune system.
to be non-inflammatory.
to be safe to the patients with pre-existing
lung inflammation.
to have an efficiency sufficient to correct
the genetic disease.
to have long duration of expression.
30. Adenovirus(non-specific
insertion)
Adenoviruses have double-
stranded DNA genomes.
Adenoviruses cause
respiratory, intestinal, and
eye infections in humans.
The common cold is caused
by an adenovirus.
Adenovirus genome can
accept large insertions of
human DNA.
Penetration into the cell is by
endocytosis.
The viral core migrates to the
nucleus where the DNA enters
through nuclear pores and
becomes incorporated into the
genome.
31. Retrovirus (non-specific
insertion):
Retroviruses are group
of RNA viruses.
Retroviruses contain two
copies of the genome in
each viral particle.
Human
immunodeficiency virus
(HIV) is a retrovirus.
On infection the ssRNA is
converted into dsDNA
copy by reverse
transcriptase and is
integrated into the host
cell genome by a viral
integrase enzyme.
32. Adeno-Associated Virus
(specific insertion)
A class of small, single-stranded
DNA viruses that can insert their
genetic material at a specific site
on chromosome 19. Penetration and
Gene Transfer mechanisms are
similar to the Adenovirus.
Several genetic disorders are related
to genes on chromosome 19 (70
known genetic disorders):
for example:
Alzheimer’s disease
Leukemia
Muscular Dystrophy
Congenital Hypothyroidism
Several Cancers (ovarian,
colorectal, etc.)
33. Herpes simplex viruses
A class of dsDNA
viruses that infect a
neurons. It has a 150
kbp dsDNA genome. It
consists of over 70
genes.e.g., Cold sores
virus
34. Non-viral DNA carriers:
Cationic liposomes
Positively charged lipids interact with negatively charged
DNA. (lipid-DNA complex).The liposome carries the
therapeutic DNA through the target cell membrane.
Advantages:
a. Stable complex
b. Can carry large sized DNA
c. Can target to specific cells
d. Does not induce immunological reactions.
Disadvantages:
a. Low transfection efficiency
b. Transient expression
c. Inhibited by serum
d. Some cell toxicity
35. Naked DNA gene therapy
◦ Intramuscular and Intravascular delivery
(liver and muscle).
◦ covalently closed circular form is more
stable that open plasmid
◦ Results in a prolonged low level expression
in vivo
◦ Very cheap
◦ DNA vaccines based on naked DNA are
unaffected by pre-existing immunity e.g.
due to maternal antibodies
36. Postnatal Gene Therapy
Correction of the deleterious effects of
genetic disease via long term integration of
gene sequences into a patient’s genome.
This property makes the use of retroviral
vectors particularly attractive when
considering effective gene delivery to correct
inherited monogenetic disorders.
37. Types of Postnatal Gene
Therapy
Gene replacement: non-functional or
defective gene is replaced by a new,
functional copy of the gene.
Can be accomplished by homologous
recombination.
Gene addition: introduction of a gene
that is able to produce a protein not
normally expressed in the cell.
i.e. Introduction of a so-called “suicide gene”
into cancer cells
38. Prenatal or in utero gene
therapy
Targets genetic diseases which require lifelong
correction
The concept of fetal gene therapy is based on
the following aims:
avoiding early-onset manifestation of life-
threatening genetic conditions
achieving permanent correction of such
diseases by stable transduction.
Avoiding immune reactions against the
therapeutic vector and transgene.
40. Benefits of prenatal gene
therapy
Provides early phenotypic correction of
genetic disease.
Demonstration of long-term postnatal
therapeutic protein production.
Tolerance to the transgenic protein
can be induced by in utero expression.
41. Risks of Gene Therapy
New gene might be inserted into wrong
location in the DNA (misfire).
Other genes may be accidentally
delivered to the cell.
The deactivated vector virus may be
contagious.
The viral vectors cause toxicity and
inflammatory responses.
The vector viruses can infect more than
one type of cell.
Over-expression of missing protein.
Immune system complications.
42. Recent Developments
Genes get into brain using liposomes
coated in polymer call polyethylene
glycol
potential for treating Parkinson’s disease
RNA interference or gene silencing to
treat Huntington’s
siRNAs used to degrade RNA of particular
sequence
abnormal protein wont be produced
Create tiny liposomes that can carry
therapeutic DNA through pores of
nuclear membrane
Sickle cell successfully treated in mice
43. Dr.B.Victor is a highly experienced professor,
recently retired from the reputed educational
institution- St. Xavier’ s College,
Palayamkottai, India-627001.
He was the dean of sciences, IQAC
coordinator and assistant controller of
examinations.
He has more than 32 years of teaching and
research experience
He has taught a diversity of courses and
guided 12 Ph.D scholars.
send your comments to :
bonfiliusvictor@gmail.com